Tuesday, June 03, 2025 | 09:43 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Alivira's animal health API facility gets US FDA approval

Approval will enable SeQuent Scientific arm to enter the $ 8-bn US veterinary healthcare market

Image courtesy: Alivira Animal Health Ltd (a part of Sequent Scientific)
premium

Image courtesy: Alivira Animal Health Ltd (a part of Sequent Scientific)

BS B2B Bureau Mumbai
Alivira Animal Health Ltd, a wholly owned subsidiary of SeQuent Scientific Limited, has received the US FDA approval for its animal health API (active pharmaceutical ingredients) facility at Visakhapatnam, Andhra Pradesh. With this, Alivira has become the first Indian animal health facility to receive the US FDA approval.

The 225-KL capacity, multi-product facility at Vizag was inspected for the first time by US FDA (Food & Drug Administration) in November 2016 and has now received Establishment Inspection Report (EIR) from US FDA. The receipt of the EIR will enable Alivira’s entry into $ 8 billion US veterinary healthcare market.

“We are pleased